75999-61-0

Basic information

• Product Name: 2,2,2-Trifluoro-N-(4-isopropylphenyl)acetaMide
• Synonyms: 2,2,2-Trifluoro-N-(4-isopropylphenyl)acetaMide
• CAS NO: 75999-61-0
• Molecular Formula: C11H12F3NO
• Molecular Weight: 231.2142896
• Mol File: 75999-61-0.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2,2,2-Trifluoro-N-(4-isopropylphenyl)acetaMide(CAS DataBase Reference)
• NIST Chemistry Reference: 2,2,2-Trifluoro-N-(4-isopropylphenyl)acetaMide(75999-61-0)
• EPA Substance Registry System: 2,2,2-Trifluoro-N-(4-isopropylphenyl)acetaMide(75999-61-0)

Safety Data

• Hazardous Substances Data: 75999-61-0(Hazardous Substances Data)

Usage

General Description

2,2,2-Trifluoro-N-(4-isopropylphenyl)acetamide is a chemical compound with the molecular formula C11H12F3NO. It is commonly used as a reagent in organic synthesis and pharmaceutical research. 2,2,2-Trifluoro-N-(4-isopropylphenyl)acetaMide is known for its wide range of applications in the development of new drugs and as a building block in the production of various medical compounds. Additionally, it has been studied for its potential as an anticonvulsant and analgesic agent. 2,2,2-Trifluoro-N-(4-isopropylphenyl)acetamide is also used as a stabilizer in various industrial processes and as a solvent in the production of pharmaceuticals.

Upstream product

• 99-88-7 4-Isopropylaniline 
• 407-25-0 trifluoroacetic anhydride 

Relevant articles and documents

HISTONE DEMETHYLASE INHIBITORS

The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted pyrido[3,4-d]pyrimidin-4-one derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.

2-Trifluoromethyl-3-quinoline carboxamides, analgesic and anti-inflammatory compositions and methods employing them

Novel 3-quinoline carboxamides of the formula STR1 wherein X' is in the 5,6,7 or 8-position and is selected from the group consisting of hydrogen, halogen, straight or branched alkyl and alkoxy of 1 to 5 carbon atoms, --CF3, --SCF3 and --OCF3, R1 is selected from the group consisting of hydrogen and alkyl of 1 to 4 carbon atoms, R2 ' is selected from the group consisting of thiazolyl, 4,5-dihydrothiazolyl, pyridinyl, oxazolyl, isoxazolyl, imidazolyl, pyrimidyl and tetrazolyl, all optionally substituted with alkyl of 1 to 4 carbon atoms and phenyl optionally substituted with at least one member of the group consisting of alkyl and alkoxy of 1 to 4 carbon atoms, --CF3, --NO2 and halogen and their non-toxic, pharmaceutically acceptable acid addition salts having analgesic and anti-inflammatory activity and novel intermediates and process for their preparation.